Showing 1 - 10 of 1,022
There is considerable controversy about the causes of regional variations in health care expenditures. We use vignettes from patient and physician surveys linked to Medicare expenditures at the Hospital Referral Region to test whether patient demand-side factors or physician supply-side factors...
Persistent link: https://www.econbiz.de/10010821905
Persistent link: https://www.econbiz.de/10011981514
Persistent link: https://www.econbiz.de/10011305226
Persistent link: https://www.econbiz.de/10009788543
There is considerable controversy about the causes of regional variations in health care expenditures. Using vignettes from patient and physician surveys linked to fee-for-service Medicare expenditures, this study asks whether patient demand-side factors or physician supply-side factors explain...
Persistent link: https://www.econbiz.de/10012459341
For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with AI-driven tools already in use...
Persistent link: https://www.econbiz.de/10013477189
We seek to explain the differences in fertility rates across high-income countries by focusing on the interaction between the increasing status of women in the workforce and their status in the household, particularly with regards to child care and home production. We observe three distinct...
Persistent link: https://www.econbiz.de/10005563008
Persistent link: https://www.econbiz.de/10008098927
Precision medicines - therapies that rely on the use of genetic, epigenetic, and protein biomarkers - create a better match between patients with specific disease subtypes and medications that are more effective for those patients. This heterogeneity in response has implications for the decision...
Persistent link: https://www.econbiz.de/10012453687
Precision medicines – therapies that rely on the use of genetic, epigenetic, and protein biomarkers – create a better match between patients with specific disease subtypes and medications that are more effective for those patients. This heterogeneity in response has implications for the...
Persistent link: https://www.econbiz.de/10012943192